Prion risk eliminated

DUPONT RelyOn Prion Inactivator will significantly reduce the potential risk of iatrogenic transmission of vCJD via surgical instruments and medical devices. Standard decontamination and sterilising procedures do not effectively remove the infectivity of prion proteins.

Used as a short pre-wash prior to standard decontamination, RelyOn Prion Inactivator gives at least 1,000,000 fold reduction in prion infectivity as proven by bio-assay and Western Blot techniques.

RelyOn Prion Inactivator is a patented combination of proteolytic enzymes, a surface active agent and a reaction potentiator resulting in a rapidly effective, pH neutral solution.

RelyOn Prion Inactivator not only reduces prion infectivity, but has a full range of microbiocidal efficacy and therefore provides operator safety for handling of instruments.

It addresses the concerns for iatrogenic transmission of vCJD expressed in the recent NICE Guidance and offers the NHS a simple and proven means to reduce the risk of secondary vCJD infections.

Latest Issues

AfPP Plymouth Regional Conference

TBC, Plymouth
10th May 2025

Theatres and Decontamination Conference

CBS Arena
20th May 2025

BAUN Day Educational Event

Hilton, Belfast
6th June 2025

EBME Expo 2025

Coventry Building Society Arena, UK
25th - 26th June 2025